// App-Quantinova.ai

: AMYLOID BETA 1–40 AND ITS UPSTREAM REGULATORY PATHWAY BACE1-AS LONG NONCODING RNA/BACE1 ARE ASSOCIATED WITH PRESENCE AND SEVERITY OF HUMAN ATHEROSCLEROTIC DISEASE

Researchers

Presenter

  • Gergiopoulos, G

Principal Investigators

  • Mavroeidis, I

  • Sopova, K

  • Sacshe, M

  • Delialis, D

  • Mareti, A

  • Kritsioti, C

  • Vlachogiannis, N

  • Laina, A

  • Mantzou, E

  • Martelli, F

  • Spyridopoulos, I

  • Gatsiou, A

  • Manios, E

  • Stellos, K

  • Stamatelopoulos, K

Medical Centers

  • Alexandra University Hospital, Department of Clinical Therapeutics, Athens, GREECE

  • Newcastle University, Newcastle Cardiovascular Disease Prevention & Resilience Hub, Newcastle Upon Tyne, UNITED KINGDOM

  • JW Goethe University, Institute of Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt Am Main, GERMANY

  • Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, Milan, ITALY

Locations

  • Greece

  • United Kingdom

  • Germany

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Dyslipidemia

  • Hypertension

  • Diabetes

  • Obesity

Biomarkers

  • High sensitivity C-reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved